Annexon appoints Mark S. Blumenkranz to board of directors
ANNX•Annexon appointed retinal surgeon and biotechnology entrepreneur Mark S. Blumenkranz to its board. Eleonora (Nora) Lad joined its scientific advisory board, and Jake Shumacher became senior vice president and ophthalmology franchise head.
1. New appointments
Annexon appointed Mark S. Blumenkranz, a retinal surgeon and biotechnology entrepreneur, to its board of directors. Eleonora (Nora) Lad, a Duke University ophthalmology professor and vice chair for clinical research, joined the scientific advisory board. Jake Shumacher joined as senior vice president and ophthalmology franchise head; he previously served as Astellas’ vice president and commercial head for IZERVAY.
